TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
Permanent URI for this collectionhttps://hdl.handle.net/20.500.14365/4
Browse
7 results
Search Results
Article Clinical Management Strategies of Cardiologists in Heart Failure with Reduced Ejection Fraction in Türkiye(Kare Publ, 2024) Türk, Uğur Önsel; Kocabaş, Umut; Özçalık, Emre; Kıvrak, Tarık; Altın, CihanAmaç: Kalp yetersizliği (KY) kılavuz önerilerinin klinik pratikte uygulanması zaman almaktadır ve genellikle gerçek yaşam şartlarında optimal düzeyde uygulanmamaktadır. Bu zorluğun önemli nedenlerinden biri hekim ile ilişkili faktörlerdir. Bu anket çalışmasının amacı, Türkiye’deki kardiyoloji uzmanlarının düşük ejeksiyon fraksiyonlu kalp yetersizliği (DEF-KY) tedavi tercihlerini belirlemektir. Yöntem: Anket çalışması 22 sorudan oluşmaktadır. Bu sorular, SurveyMonkey üzerinden yayınlanmış ve anket katılım linki birçok sosyal medya aracı üzerinden hekimlere ulaştırılmıştır. Bulgular: Anket çalışmasına Türkiye’de görev yapmakta olan 177 kardiyoloji uzmanı ve asistanı katıldı. Katılımcıların ortalama yaşı 39.5, %73.3’ü erkek, %38.7’si eğitim ve araştırma hastanelerinde görev yapmakta idi ve sadece %10.2’si kendisini KY uzmanı olarak tanımlamaktaydı. Katılımcıların %80.1’i, DEF-KY tanısı için sınır ejeksiyon fraksiyonu değerini %40 olarak kabul ettiklerini belirttiler. Hekimlerin %52.6’sı anjiyotensin reseptör-neprilisin inhibitörü (ARNi) tedavisini ‘‘en etkili KY tedavisi’’ olarak kabul ettiklerini belirtmelerine karşın, %62.7’si ilacın geri ödeme kısıtlılıkları ve fiyatı nedeniyle, DEF-KY tedavisine ARNi yerine anjiyotensin dönüştürücü enzim inhibitörü (ADEi) ile başlamak zorunda kaldıklarını belirttiler. Katılımcıların %52.3’ü tedaviye farklı bir KY ilaç sınıfını eklemenin, halihazırda kullanılan ilaçların dozunu arttırmaktan daha önemli olduğunu belirttiler. Hekimlerin %69.5’i yeni tanı KY hastalarında, hastane yatışı sırasında dört KY ilaç sınıfını aynı anda başlamanın mümkün olduğunu belirttiler. Buna karşın günlük pratiklerinde, sırasıyla ADEi/ARNI, beta–bloker, mineralokortikoid reseptör antagonisti ve sodyum-glukoz ko-transporter 2 inhibitörlerini başladıkları sıralı yaklaşımı daha çok tercih ettiklerini belirttiler. Sonuç: Bu anket çalışması, kılavuz önerileri ile gerçek yaşam uygulamaları arasında önemli farklılıklar olduğunu ortaya koymaktadır. Kılavuz önerilerinin, klinik pratikte uygulanabilmesi için sağlık sağlayıcıların gerekli önlemleri almalarına ve düzenlemeleri yapmalarına ihtiyaç vardır.Article Citation - WoS: 1Citation - Scopus: 1Myocardial Infarction in Young Adults: Diagnosis Begins Through Inspection(Kare Publ, 2024) Özpelit, Mehmet Emre; Kumral, Zeynep; Özpelit, Ebru; Çolak, AyseSpontan koroner arter diseksiyonu (SKAD), genellikle orta yaşlı kadınları etkileyen nadir bir akut koroner sendrom formudur. Genetik vaskülopatiler de dahil olmak üzere bağ dokusu hastalıkları SCAD’ye yol açan önemli predispozan durumlardan biridir. Bu yazıda, anterior miyokard enfarktüsü geçiren ve vasküler tip Ehler-Danlos sendromu tanısı alan 36 yaşında bir erkek hasta sunulmuş ve literatür gözden geçirilmiştir.Article Determination of Eight Hub Genes and Functional Pathways Affecting Both the Survival of Early- and Late-Stage Colon Cancer Patients(Kare Publ, 2023) Ayna Duran, Gizem; Sert, Fatma; Duran, Assist. Prof. Dr. Gizem Ayna; Duran, Gizem AynaOBJECTIVEThe stage of colon cancer (CC) and therefore the level at which the treatment is initiated affects the survival of CC patients. In our study, we aimed to identify the common survival-related genes in both early-and late-stage CC patients.METHODSInformation on the demographic characteristics of 581 patients and microarray expression profiles (GSE39582) were obtained from the gene expression omnibus database. Survival analysis was per-formed using univariate and multivariate Cox regression methods with the help of R3.53 programming language and Kaplan-Meier graphics through the R software Survival package. ShinyGO v0.741 gene ontology enrichment analysis was performed to clarify the common and functional pathways related to both early-and late-stage CC cancer patients' data.RESULTSCox regression analysis indicated that overall survival and relapse-free survival of CC patients were strongly influenced by stage. Genes that significantly affect prognosis and survival in early-and late -stage CC patients were identified. As a result of gene enrichment analysis, arginine binding, oxidore-ductase activity, and methylcytosine dioxygenase activity and related eight hub genes (TM4SF5, NOS3, Ten eleven translocation [TET1], TET3, JMJD7, AKR1C1, prenylcysteine oxidase 1 like, Methionine sulfoxide reductase A) were identified.CONCLUSIONAccording to our results, it might be considered that developing new treatment strategies based on eight hub-genes related to arginine binding, oxidoreductase activity, and methylcytosine dioxygenase activity detected at different stages of CC might increase the success of targeted therapies.Article Citation - WoS: 3Citation - Scopus: 3Real-World Evaluation of Anticoagulant Treatment Patterns in Patients With Atrial Fibrillation: Data From Multicenter Rota Study [2023](Kare Publ, 2023) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Özdemir, İbrahim; Genç, Ömer; Altın, CihanObjective: Oral anticoagulant therapy is the cornerstone of atrial fibrillation management to prevent stroke and systemic embolism. However, there is limited real-world information regarding stroke and systemic embolism prevention strategies in patients with atrial fibrillation. The aim of the ROTA study is to obtain the real-world data of anticoagulant treatment patterns in patients with atrial fibrillation. Materials and Methods: The ROTA study is a prospective, multicenter, and observational study that included 2597 patients with atrial fibrillation. The study population was recruited from 41 cardiology outpatient clinics between January 2021 and May 2021.Results: The median age of the study population was 72 years (range: 22-98 years) and 57.4% were female. The median CHA2DS2-VASc and HAS-BLED scores were 4 (range: 0-9) and 1 (range: 0-6), respectively. Vitamin K antagonists and direct oral anticoagulants were used in 15.9% and 79.4% of patients, respectively. The mean time in therapeutic range was 52.9% for patients receiving vitamin K antagonists, and 76% of those patients had an inadequate time in therapeutic range with <70%. The most common prescribed direct oral anticoagulants were rivaroxaban (38.1%), apixaban (25.5%), and edoxaban (11.2%). The rate of overuse of vitamin K antagonists and direct oral anticoagulants was high (76.1%) in patients with low stroke risk, and more than one-fourth of patients on direct oral anticoagulant therapy were receiving a reduced dose of direct oral anticoagulants. Among patients who were on direct oral anticoagulant treatment, patients with apixaban treatment were older, had higher CHA2DS2- VASc and HAS-BLED scores, and had lower creatinine clearance than the patients receiving other direct oral anticoagulants.Conclusions: The ROTA study provides important real-world information about anticoagulant treatment patterns in patients with atrial fibrillation.Conference Object Real-World Evaluation of Anticoagulant Treatment Patterns in Patients With Atrial Fibrillation: Data From Multicenter Rota Study [2022](Kare Publ, 2023) Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan; Özçalık, Emre; Şengör, Büşra Güvendi; Sen, Taner; Kaplan, Mehmet; Dal, Ahmet; Dogdus, Mustafa; Şahin, Şeyda[Abstract Not Available]Article Citation - WoS: 8Citation - Scopus: 7Evaluation of Demographic and Clinical Characteristics of Female Patients Presenting With Minoca and Differences Between Male Patients: a Subgroup Analysis of Minoca-Tr Registry(Kare Publ, 2022-01-06) Gok, Gulay; Coner, Ali; Cinar, Tufan; Kilic, Salih; Yenercag, Mustafa; Oz, Ahmet; Ekmekci, Cenk; Türk, Uğur Önsel; Zoghi, Mehdi; Ergene, Asim OktayObjective: Although the prevalence and rate of myocardial infarction with non-obstructive coronary arteries (MINOCA) are higher in women than in men in previous cohorts, potential demographic and clinical differences between women who are diagnosed with MINOCA versus myocardial infarction with obstructive coronary arteries (MIOCA) have not been studied till date. In this study, we aimed to document these characteristics and to compare them between female patients with MINOCA and MIOCA. Methods: The study was a subgroup analysis of the MINO-CA-TR study. The study was a multi-center, observational cohort study that was conducted in Turkey between March 2018 and October 2018. In this study, 477 (29.3%) female patients who had been diagnosed with acute myocardial infarction were evaluated. Results: Of these women, 49 (10.3%) were diagnosed with MINOCA (mean age 58.9 +/- 12.9 years) and 428 (89.7%) had a final diagnosis of MIOCA (mean age 67.4 +/- 11.8 years). The prevalence of hypertension, hyperlipidemia, and diabetes mellitus was significantly lower in the MINOCA group than in the MIOCA group. In addition, the MINOCA group had higher rates of recent flu history and non-ST elevation myocardial infarction (NSTEMI) presentation than the MIOCA group. There were significant clinical differences in patients with MINOCA in terms of sex. The female patients were older, had higher systolic blood pressures, and lower hemoglobin levels than male patients. Conclusion: The study revealed that the prevalence of traditional coronary artery disease risk factors was lower in female patients with MINOCA than in those who had final diagnosis of MIOCA.Article Citation - WoS: 7An in Vitro Study in Which New Boron Derivatives Maybe an Option for Breast Cancer Treatment(Kare Publ, 2019) Simsek, Fatma; Inan, Sevinc; Korkmaz, MehmetObjectives: We aimed to investigate the distribution of immunoreactivities of vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), and inducible NOS (iNOS) on breast cancer cells in response to treatment with boron derivatives. Methods: We initially analyzed the cytotoxic effect and IC50 value of boron by MTT assay. For the evaluation of the angiogenesis, expression level of antibodies was detected to following boron derivatives such as boric acid, boron penta (BP), and T-Boron (DPD) in the absence of boron treatment using the indirect immunohistochemical method.The evaluation of these staining was done using the H-scoring system. Results: It was found that immunoreactivities of VEGF, eNOS, and iNOS increased on control compared to those of the cells of MDA-MB231 human breast cancer cell line. Following boron derivatives treatment, it was observed that they were inhibited the VEGF/NOS labeling in MDA-MB-231 breast cancer cells. Conclusion: The present data suggest that BP, especially DPD, inhibits the angiogenesis of breast cancer cells through VEGF pathway. From this point, these boron derivatives may provide a novel therapeutic approach for breast cancer treatment.